{
  "DOI": "10.1038/s41431-019-0508-0",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-019-0508-0",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\n\u003cjats:p\u003eRare diseases, an emerging global public health priority, require an evidence-based estimate of the global point prevalence to inform public policy. We used the publicly available epidemiological data in the Orphanet database to calculate such a prevalence estimate. Overall, Orphanet contains information on 6172 unique rare diseases; 71.9% of which are genetic and 69.9% which are exclusively pediatric onset. Global point prevalence was calculated using rare disease prevalence data for predefined geographic regions from the ‘Orphanet Epidemiological file’ (\u003cjats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"http://www.orphadata.org/cgi-bin/epidemio.html\"\u003ehttp://www.orphadata.org/cgi-bin/epidemio.html\u003c/jats:ext-link\u003e). Of the 5304 diseases defined by point prevalence, 84.5% of those analysed have a point prevalence of \u0026lt;1/1 000 000. However 77.3–80.7% of the population burden of rare diseases is attributable to the 4.2% (\u003cjats:italic\u003en\u003c/jats:italic\u003e = 149) diseases in the most common prevalence range (1–5 per 10 000). Consequently national definitions of ‘Rare Diseases’ (ranging from prevalence of 5 to 80 per 100 000) represent a variable number of rare disease patients despite sharing the majority of rare disease in their scope. Our analysis yields a conservative, evidence-based estimate for the population prevalence of rare diseases of 3.5–5.9%, which equates to 263–446 million persons affected globally at any point in time. This figure is derived from data from 67.6% of the prevalent rare diseases; using the European definition of 5 per 10 000; and excluding rare cancers, infectious diseases, and poisonings. Future registry research and the implementation of rare disease codification in healthcare systems will further refine the estimates.\u003c/jats:p\u003e",
  "alternative-id": [
    "508"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "13 April 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "21 August 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "29 August 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "16 September 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Nguengang Wakap",
      "given": "Stéphanie",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-0967-0476",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lambert",
      "given": "Deborah M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Olry",
      "given": "Annie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rodwell",
      "given": "Charlotte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gueydan",
      "given": "Charlotte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lanneau",
      "given": "Valérie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Murphy",
      "given": "Daniel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Le Cam",
      "given": "Yann",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-4308-6337",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Rath",
      "given": "Ana",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        9,
        16
      ]
    ],
    "date-time": "2019-09-16T14:03:17Z",
    "timestamp": 1568642597000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:00:32Z",
    "timestamp": 1684616432000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        1
      ]
    ],
    "date-time": "2024-05-01T15:21:05Z",
    "timestamp": 1714576865376
  },
  "is-referenced-by-count": 707,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2019,
        9,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            9,
            16
          ]
        ],
        "date-time": "2019-09-16T00:00:00Z",
        "timestamp": 1568592000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            9,
            16
          ]
        ],
        "date-time": "2019-09-16T00:00:00Z",
        "timestamp": 1568592000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-019-0508-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0508-0",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0508-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "165-173",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2019,
        9,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        9,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "R Valdez",
      "first-page": "E05",
      "journal-title": "Prev Chronic Dis",
      "key": "508_CR1",
      "unstructured": "Valdez R, Ouyang L, Bolen J. Public health and rare diseases: oxymoron no more. Prev Chronic Dis. 2016;13:E05.",
      "volume": "13",
      "year": "2016"
    },
    {
      "key": "508_CR2",
      "unstructured": "EURORDIS. Rare diseases: understanding this public health priority. 2005. \nhttp://www.eurordis.org/publication/rare-diseases-understanding-public-health-priority\n\n. Accessed 15 Jan 2019."
    },
    {
      "DOI": "10.1111/j.1467-9566.2008.01143.x",
      "author": "C Huyard",
      "doi-asserted-by": "publisher",
      "first-page": "463",
      "journal-title": "Soc Health Illn",
      "key": "508_CR3",
      "unstructured": "Huyard C. How did uncommon disorders become ‘rare diseases’? History of a boundary object. Soc Health Illn. 2009;31:463–77.",
      "volume": "31",
      "year": "2009"
    },
    {
      "key": "508_CR4",
      "unstructured": "European Union. Regulation (EC) N°141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. 2000. \nhttp://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:EN:PDF\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR5",
      "unstructured": "Van Weely S, Leufkens HGM. Priority Medicines for Europe and the World “A Public Health Approach to Innovation”: Background Paper 6.19 Rare Diseases. 2004. \nhttps://www.who.int/medicines/areas/priority_medicines/BP6_19Rare.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR6",
      "unstructured": "European Union. Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare. 2011. \nhttps://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:EN:PDF\n\n. Accessed 15 Jan 2019."
    },
    {
      "DOI": "10.1016/j.jval.2015.05.008",
      "author": "T Richter",
      "doi-asserted-by": "publisher",
      "first-page": "906",
      "journal-title": "Value Health.",
      "key": "508_CR7",
      "unstructured": "Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare disease terminology and definitions-A systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18:906–14.",
      "volume": "18",
      "year": "2015"
    },
    {
      "key": "508_CR8",
      "unstructured": "Council of the European Union. Council recommendation on action in the field of rare diseases— 2947th employment, social policy, health and consumer affairs—council meeting. 2009. \nhttp://www.europlanproject.eu/Resources/docs/CouncilRecommendation_2009-C151-02.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR9",
      "unstructured": "National Institute of Health. Public Law 97–414 97th Congress. Jan 4, 1983. \nhttps://history.nih.gov/research/downloads/PL97-414.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "author": "P Song",
      "first-page": "3",
      "journal-title": "Intractable Rare Dis Res",
      "key": "508_CR10",
      "unstructured": "Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: current status and future perspectives. Intractable Rare Dis Res. 2012;1:3–9.",
      "volume": "1",
      "year": "2012"
    },
    {
      "key": "508_CR11",
      "unstructured": "Department of Health. Therapeutic goods administration. 2018. \nhttps://www.tga.gov.au/publication/orphan-drug-designation-eligibility-criteria\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR12",
      "unstructured": "Taiwan Foundation for rare disorders. About rare diseases. 2018. \nhttp://www.tfrd.org.tw\n\n. Accessed 15 Jan 2019."
    },
    {
      "DOI": "10.1177/009286150003400319",
      "author": "S Makoto",
      "doi-asserted-by": "publisher",
      "first-page": "829",
      "journal-title": "Drug Inf J",
      "key": "508_CR13",
      "unstructured": "Makoto S, Kiyohito N. Development of orphan drugs in Japan: effects of a support system for development of orphan drugs in Japan. Drug Inf J. 2000;34:829–37.",
      "volume": "34",
      "year": "2000"
    },
    {
      "DOI": "10.5582/irdr.2017.01009",
      "author": "Y Cui",
      "doi-asserted-by": "publisher",
      "first-page": "148",
      "journal-title": "Intractable Rare Dis Res.",
      "key": "508_CR14",
      "unstructured": "Cui Y, Han J. Defining rare diseases in China. Intractable Rare Dis Res. 2017;6:148–9.",
      "volume": "6",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13023-014-0173-x",
      "author": "RM Leadley",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis.",
      "key": "508_CR15",
      "unstructured": "Leadley RM, Lang S, Misso K, Bekkering T, Ross J, Akiyama T, et al. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis. 2014;9:173.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1093/qjmed/hcr116",
      "author": "EC Harknett",
      "doi-asserted-by": "publisher",
      "first-page": "971",
      "journal-title": "QJM.",
      "key": "508_CR16",
      "unstructured": "Harknett EC, Chang WY, Byrnes S, Johnson J, Lazor R, Cohen MM, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011;104:971–9.",
      "volume": "104",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s00403-014-1531-1",
      "author": "E Alpsoy",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "journal-title": "Arch Dermatol Res.",
      "key": "508_CR17",
      "unstructured": "Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res. 2015;307:291–8.",
      "volume": "307",
      "year": "2015"
    },
    {
      "DOI": "10.1093/eurheartj/ehu274",
      "author": "M Cuchel",
      "doi-asserted-by": "publisher",
      "first-page": "2146",
      "journal-title": "Eur Heart J.",
      "key": "508_CR18",
      "unstructured": "Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014;35:2146–57.",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00383-012-3214-3",
      "author": "C Hallal",
      "doi-asserted-by": "publisher",
      "first-page": "1211",
      "journal-title": "Pediatr Surg Int",
      "key": "508_CR19",
      "unstructured": "Hallal C, Kieling CO, Nunes DL, Ferreira CT, Peterson G, Barros SG, et al. Diagnosis, misdiagnosis, and associated diseases of achalasia in children and adolescents: a twelve-year single center experience. Pediatr Surg Int. 2012;28:1211–7.",
      "volume": "28",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.bbadis.2015.02.008",
      "author": "C Rodwell",
      "doi-asserted-by": "publisher",
      "first-page": "2329",
      "journal-title": "Biochim Biophys Acta.",
      "key": "508_CR20",
      "unstructured": "Rodwell C, Aymé S. Rare disease policies to improve care for patients in Europe. Biochim Biophys Acta. 2015;1852:2329.",
      "volume": "1852",
      "year": "2015"
    },
    {
      "key": "508_CR21",
      "unstructured": "Orphanet—2017 activity report, Orphanet report series, reports collection, September 2018 (V1.1). 2018. \nhttps://www.orpha.net/orphacom/cahiers/docs/GB/ActivityReport2017.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR22",
      "unstructured": "European Commission. Communication from the commission to the European parliament, the council, the European economic and social committee and the committee of the regions on rare diseases: Europe’s challenges. 2008. \nhttps://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR23",
      "unstructured": "IRDiRC. IRDiRC Recognized Resources. 2018. \nhttp://www.irdirc.org/research/irdirc-recognized-resources/current-irdirc-recognized-resources/\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR24",
      "unstructured": "ELIXIR. ELIXIR core data resources. 2017. \nhttps://www.elixir-europe.org/platforms/data/core-data-resources\n\n. Accessed 15 Jan 2019."
    },
    {
      "DOI": "10.1002/humu.22078",
      "author": "Ana Rath",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "issue": "5",
      "journal-title": "Human Mutation",
      "key": "508_CR25",
      "unstructured": "Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S. Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users’. Hum Mutat. 2012;33:803–8.",
      "volume": "33",
      "year": "2012"
    },
    {
      "key": "508_CR26",
      "unstructured": "Orphanet. Procedural document on the inventory of rare diseases, Orphanet, April 2017, Number 01. 2017. \nhttp://www.orpha.net/orphacom/cahiers/docs/GB/eproc_disease_inventory_PR_R1_Nom_04.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR27",
      "unstructured": "Orphanet. Procedural document on epidemiology of rare diseases in Orphanet, February 2019, Number 01. 2019. \nhttps://www.orpha.net/orphacom/cahiers/docs/GB/Epidemiology_in_Orphanet_R1_Ann_Epi_EP_05.pdf\n\n. Accessed 8 Feb 2019."
    },
    {
      "key": "508_CR28",
      "unstructured": "NGO committee for rare diseases. Statements of support to the NGO committee for rare diseases. 2016. \nhttps://www.ngocommitteerarediseases.org/statements-of-support/\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR29",
      "unstructured": "Orphanet. Free datasets powered by Orphanet. 2018. \nhttp://www.orphadata.org/cgi-bin/index.php\n\n. Accessed 1 Oct 2018."
    },
    {
      "key": "508_CR30",
      "unstructured": "Population, Total | Data. n.d. \nhttps://data.worldbank.org/indicator/SP.POP.TOTL?year_high_desc=true\n\n. Accessed 5 Oct 2018."
    },
    {
      "key": "508_CR31",
      "unstructured": "Eurostat. First population estimates EU population up to almost 512 million at 1 January 2017 Increase driven by migration. 2017. \nhttps://ec.europa.eu/eurostat/documents/2995521/8102195/3-10072017-AP-EN.pdf/a61ce1ca-1efd-41df-86a2-bb495daabdab\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR32",
      "unstructured": "NCOD (National Commission on Orphan Diseases). Report of the National Commission in Orphan Diseases. Rockville, MD: Public Health Service, US Department of Health and Human Services; 1989."
    },
    {
      "key": "508_CR33",
      "unstructured": "IOM (Institute of Medicine). Rare Diseases and Orphan Products: Accelerating Research and Development. Washington, DC: The National Academies Press; 2010. p. 51."
    },
    {
      "DOI": "10.1186/1750-1172-9-37",
      "author": "M Mazzucato",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "journal-title": "Orphanet J Rare Dis",
      "key": "508_CR34",
      "unstructured": "Mazzucato M, Visonà Dalla Pozza L, Manea S, Minichiello C, Facchin P. A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region’s rare diseases registry. Orphanet J Rare Dis 2014;9:37–48.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2016.143",
      "author": "CE Walker",
      "doi-asserted-by": "publisher",
      "first-page": "546",
      "journal-title": "Genet Med",
      "key": "508_CR35",
      "unstructured": "Walker CE, Mahede T, Davis G, Miller LJ, Girschik J, Brameld K, et al. The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genet Med. 2017;19:546–52.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13023-018-0892-5",
      "author": "ATG Chiu",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "508_CR36",
      "unstructured": "Chiu ATG, Chung CCY, Wong WHS, Lee SL, Chung BHY. Healthcare burden of rare diseases in Hong Kong - adopting ORPHAcodes in ICD-10 based healthcare administrative datasets. Orphanet J Rare Dis. 2018;13:147.",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ajmg.a.61124",
      "author": "Carlos R. Ferreira",
      "doi-asserted-by": "publisher",
      "first-page": "885",
      "issue": "6",
      "journal-title": "American Journal of Medical Genetics Part A",
      "key": "508_CR37",
      "unstructured": "Ferreira CR. The burden of rare diseases. Am J Med Genet. 2019;179:885–92.",
      "volume": "179",
      "year": "2019"
    },
    {
      "key": "508_CR38",
      "unstructured": "Orphanet. Prevalence of rare diseases: bibliographic data, Orphanet report series, rare diseases collection, January 2019, number 2: diseases listed by decreasing prevalence, incidence or number of published cases. 2019. \nhttp://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_decreasing_prevalence_or_cases.pdf\n\n. Accessed 30 July 2019."
    },
    {
      "DOI": "10.1016/j.ejca.2011.08.008",
      "author": "G Gatta",
      "doi-asserted-by": "publisher",
      "first-page": "2493",
      "journal-title": "Eur J Cancer",
      "key": "508_CR39",
      "unstructured": "Gatta G, van der Zwanb AM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47:2493–511.",
      "volume": "47",
      "year": "2011"
    },
    {
      "key": "508_CR40",
      "unstructured": "European medicines agency points to consider on the calculation and reporting of the prevalence of a condition for orphan designation. 2002. \nhttp://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/09/WC500003773.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "DOI": "10.2147/DMSO.S130810",
      "author": "E Chiquette",
      "doi-asserted-by": "publisher",
      "first-page": "375",
      "journal-title": "Diabetes Metab Syndr Obes.",
      "key": "508_CR41",
      "unstructured": "Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes. 2017;10:375–83.",
      "volume": "10",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0190430",
      "author": "A Solazzo",
      "doi-asserted-by": "publisher",
      "first-page": "e0190430",
      "journal-title": "PLoS ONE.",
      "key": "508_CR42",
      "unstructured": "Solazzo A, Testa F, Giovanella S, Busutti M, Furci L, Carrera P, et al. The prevalence of autosomal dominant polycystic kidney disease (ADPKD): a meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition. PLoS ONE. 2018;13:e0190430.",
      "volume": "13",
      "year": "2018"
    },
    {
      "key": "508_CR43",
      "unstructured": "Commission Expert Group on Rare Diseases, recommendation on ways to improve codification for rare diseases in health information systems. 2014. \nhttps://ec.europa.eu/health/sites/health/files/rare_diseases/docs/recommendation_coding_cegrd_en.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR44",
      "unstructured": "EUCERD. EUCERD core recommendations on rare disease patient registration and data collection to the European Commission, member states and all stakeholders. 2013. \nhttp://www.eucerd.eu/wp-content/uploads/2013/06/EUCERD_Recommendations_RDRegistryDataCollection_adopted.pdf\n\n. Accessed 15 Jan 2019."
    },
    {
      "key": "508_CR45",
      "unstructured": "RD-ACTION. Overview report on the state of the art of rare disease activities in Europe. 2018. \nhttp://www.rd-action.eu/wp-content/uploads/2018/09/Final-Overview-Report-State-of-the-Art-2018-version.pdf\n\n. Accessed 15 Jan 2019."
    }
  ],
  "reference-count": 45,
  "references-count": 45,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-019-0508-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "28"
}